Yabao Pharmaceutical announced on August 7 that the company signed a technology transfer agreement for new traditional Chinese medicine projects with Shanxi University on August 6, transferring the clinical trial approval documents, patent rights, and related technical information. of the Class 6.1 Chinese medicine (current classification 1.1) "Chaigui granules" owned by Shanxi University for 26 million yuan.

This transfer is helpful for the company to quickly expand its research and development pipeline for innovative traditional Chinese medicine drugs and accelerate the development of new products.

From Jiemian News

August 9th, 2023